Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001999371-24-006344
Filing Date
2024-05-20
Accepted
2024-05-20 16:32:25
Documents
3
Group Members
22NW FUND GP, LLC22NW GP, INC.22NW, LPARON R. ENGLISHBEAU GARRETTBRYSON O. HIRAI-HADLEYELAINE THIBODEAUJASON ARYEHMATTHEW KORENBERGNATHANIEL CALLOWAYRICHARD CUNNINGHAM

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP lifecore_sc13da-051624.htm SC 13D/A 357990
2 JOINT FILING AGREEMENT ex99-1.htm EX-99.1 31945
3 POWERS OF ATTORNEY ex99-2.htm EX-99.2 40875
  Complete submission text file 0001999371-24-006344.txt   432798
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: SC 13D/A | Act: 34 | File No.: 005-45181 | Film No.: 24965095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Filed by) CIK: 0001640809 (see all company filings)

EIN.: 473303449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A